Compare · GUTS vs INSP
GUTS vs INSP
Side-by-side comparison of Fractyl Health Inc. (GUTS) and Inspire Medical Systems Inc. (INSP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GUTS and INSP operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- INSP is the larger of the two at $1.80B, about 154.0x GUTS ($11.7M).
- GUTS has been more active in the news (8 items in the past 4 weeks vs 4 for INSP).
- INSP has more recent analyst coverage (25 ratings vs 6 for GUTS).
- Company
- Fractyl Health Inc.
- Inspire Medical Systems Inc.
- Price
- -
- -
- Market cap
- $11.7M
- $1.80B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- 2018
- News (4w)
- 8
- 4
- Recent ratings
- 6
- 25
Inspire Medical Systems Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Latest GUTS
- SEC Form 3 filed by new insider Wartell Michael J.
- Fractyl Health Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026
- Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization
- Fractyl Health Announces Market Research Highlighting Substantial Patient Interest in a One-Time Procedural Approach to Post-GLP-1 Weight Maintenance
- SEC Form 8-K filed by Fractyl Health Inc.
- Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Fractyl Health, Inc. to Contact Law Firm
- GUTS UPCOMING DEADLINE: Levi & Korsinsky Alerts Fractyl Health, Inc. Stockholders of Securities Class Action - Contact the Firm
- SEC Form 8-K filed by Fractyl Health Inc.
Latest INSP
- Amendment: SEC Form SCHEDULE 13G/A filed by Inspire Medical Systems Inc.
- Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference
- SEC Form 10-Q filed by Inspire Medical Systems Inc.
- Inspire Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 4 filed by Inspire Medical Systems Inc.
- SEC Form 4 filed by Inspire Medical Systems Inc.
- SEC Form 4 filed by Inspire Medical Systems Inc.
- SEC Form 4 filed by Inspire Medical Systems Inc.
- Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
- Barclays initiated coverage on Inspire Medical Systems with a new price target